These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29125018)

  • 41. Uses of clozapine in nonschizophrenic patients.
    Frankenburg FR; Zanarini MC
    Harv Rev Psychiatry; 1994; 2(3):142-50. PubMed ID: 9384895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics.
    Melkersson K; Lewitt M; Hall K
    Neuro Endocrinol Lett; 2015; 36(5):465-80. PubMed ID: 26707048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clozapine safety, 35 years later.
    Raja M
    Curr Drug Saf; 2011 Jul; 6(3):164-84. PubMed ID: 22122392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E; Fleischhaker C; Clement HW; Remschmidt H
    J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of the metabolic syndrome among patients receiving clozapine.
    Lamberti JS; Olson D; Crilly JF; Olivares T; Williams GC; Tu X; Tang W; Wiener K; Dvorin S; Dietz MB
    Am J Psychiatry; 2006 Jul; 163(7):1273-6. PubMed ID: 16816234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose related response to clozapine in a state psychiatric hospital population: a naturalistic study.
    Gordon BJ; Milke DJ
    Psychiatr Q; 1996; 67(1):65-74. PubMed ID: 8623040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The incidence and characteristics of clozapine- induced fever in a local psychiatric unit in Hong Kong.
    Pui-yin Chung J; Shiu-yin Chong C; Chung KF; Lai-wah Dunn E; Wai-nang Tang O; Chan WF
    Can J Psychiatry; 2008 Dec; 53(12):857-62. PubMed ID: 19087484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
    Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
    Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Side-effects and treatment with clozapine: a comparison between the views of consumers and their clinicians.
    Hodge K; Jespersen S
    Int J Ment Health Nurs; 2008 Feb; 17(1):2-8. PubMed ID: 18211398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.
    Lieberman JA; Phillips M; Gu H; Stroup S; Zhang P; Kong L; Ji Z; Koch G; Hamer RM
    Neuropsychopharmacology; 2003 May; 28(5):995-1003. PubMed ID: 12700715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clozapine for treatment-refractory mania.
    Calabrese JR; Kimmel SE; Woyshville MJ; Rapport DJ; Faust CJ; Thompson PA; Meltzer HY
    Am J Psychiatry; 1996 Jun; 153(6):759-64. PubMed ID: 8633686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study.
    Kluge M; Schuld A; Himmerich H; Dalal M; Schacht A; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T
    J Clin Psychopharmacol; 2007 Dec; 27(6):662-6. PubMed ID: 18004133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM
    Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia.
    Eskelinen S; Sailas E; Joutsenniemi K; Holi M; Suvisaari J
    Nord J Psychiatry; 2015 Jul; 69(5):339-45. PubMed ID: 25981178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder.
    Reid WH; Mason M; Hogan T
    Psychiatr Serv; 1998 Aug; 49(8):1029-33. PubMed ID: 9712207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.
    Lieberman JA; Safferman AZ; Pollack S; Szymanski S; Johns C; Howard A; Kronig M; Bookstein P; Kane JM
    Am J Psychiatry; 1994 Dec; 151(12):1744-52. PubMed ID: 7977880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
    Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obsessive-compulsive symptoms in adjunctive therapy with lamotrigine in clozapine-medicated patients.
    Szmulewicz AG; Valerio MP; Smith JM
    Schizophr Res; 2015 Aug; 166(1-3):364-5. PubMed ID: 26058675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.